Literature DB >> 30221345

Genomic screening in rare disorders: New mutations and phenotypes, highlighting ALG14 as a novel cause of severe intellectual disability.

Malin Kvarnung1,2, Fulya Taylan1, Daniel Nilsson1,2,3, Britt-Marie Anderlid1,2, Helena Malmgren1,2, Kristina Lagerstedt-Robinson1,2, Eva Holmberg4, Magnus Burstedt4, Magnus Nordenskjöld1,2, Ann Nordgren1,2, Elisabeth S Lundberg1,2.   

Abstract

We have investigated 20 consanguineous families with multiple children affected by rare disorders. Detailed clinical examinations, exome sequencing of affected as well as unaffected family members and further validation of likely pathogenic variants were performed. In 16/20 families, we identified pathogenic variants in autosomal recessive disease genes (ALMS1, PIGT, FLVCR2, TFG, CYP7B1, ALG14, EXOSC3, MEGF10, ASAH1, WDR62, ASPM, PNPO, ERCC5, KIAA1109, RIPK4, MAN1B1). A number of these genes have only rarely been reported previously and our findings thus confirm them as disease genes, further delineate the associated phenotypes and expand the mutation spectrum with reports of novel variants. We highlight the findings in two affected siblings with splice altering variants in ALG14 and propose a new clinical entity, which includes severe intellectual disability, epilepsy, behavioral problems and mild dysmorphic features, caused by biallelic variants in ALG14.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ALG14; KIAA1109; exome sequencing; genome screening; intellectual disability; rare disorders

Mesh:

Substances:

Year:  2018        PMID: 30221345     DOI: 10.1111/cge.13448

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

Review 1.  KIAA1109 gene mutation in surviving patients with Alkuraya-Kučinskas syndrome: a review of literature.

Authors:  Kishore Kumar; Anikha Bellad; Pramada Prasad; Satish Chandra Girimaji; Babylakshmi Muthusamy
Journal:  BMC Med Genet       Date:  2020-06-26       Impact factor: 2.103

2.  Ataxia in Patients With Bi-Allelic NFASC Mutations and Absence of Full-Length NF186.

Authors:  Malin Kvarnung; Mansoureh Shahsavani; Fulya Taylan; Mohsen Moslem; Nicole Breeuwsma; Loora Laan; Jens Schuster; Zhe Jin; Daniel Nilsson; Agne Lieden; Britt-Marie Anderlid; Magnus Nordenskjöld; Elisabeth Syk Lundberg; Bryndis Birnir; Niklas Dahl; Ann Nordgren; Anna Lindstrand; Anna Falk
Journal:  Front Genet       Date:  2019-09-24       Impact factor: 4.599

3.  Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles.

Authors:  Nobuhiko Okamoto; Tatsuyuki Ohto; Takashi Enokizono; Yoshinao Wada; Tomohiro Kohmoto; Issei Imoto; Yoshimi Haga; Junichi Seino; Tadashi Suzuki
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

Review 4.  XPG: a multitasking genome caretaker.

Authors:  Alba Muniesa-Vargas; Arjan F Theil; Cristina Ribeiro-Silva; Wim Vermeulen; Hannes Lans
Journal:  Cell Mol Life Sci       Date:  2022-03-01       Impact factor: 9.207

5.  An in vitro assay for enzymatic studies on human ALG13/14 heterodimeric UDP-N-acetylglucosamine transferase.

Authors:  Chun-Di Wang; Si Xu; Shuai Chen; Zheng-Hui Chen; Neta Dean; Ning Wang; Xiao-Dong Gao
Journal:  Front Cell Dev Biol       Date:  2022-09-19

6.  Translational balancing questioned: Unaltered glycosylation during disulfiram treatment in mannosyl-oligosaccharide alpha-1,2-mannnosidase-congenital disorders of glycosylation (MAN1B1-CDG).

Authors:  Lisa Kemme; Marianne Grüneberg; Janine Reunert; Stephan Rust; Julien Park; Cordula Westermann; Yoshinao Wada; Oliver Schwartz; Thorsten Marquardt
Journal:  JIMD Rep       Date:  2021-03-20

7.  An update of pathogenic variants in ASPM, WDR62, CDK5RAP2, STIL, CENPJ, and CEP135 underlying autosomal recessive primary microcephaly in 32 consanguineous families from Pakistan.

Authors:  Sajida Rasool; Jamshaid Mahmood Baig; Abubakar Moawia; Ilyas Ahmad; Maria Iqbal; Syeda Seema Waseem; Maria Asif; Uzma Abdullah; Ehtisham Ul Haq Makhdoom; Emrah Kaygusuz; Muhammad Zakaria; Shafaq Ramzan; Saif Ul Haque; Asif Mir; Iram Anjum; Mehak Fiaz; Zafar Ali; Muhammad Tariq; Neelam Saba; Wajid Hussain; Birgit Budde; Saba Irshad; Angelika Anna Noegel; Stefan Höning; Shahid Mahmood Baig; Peter Nürnberg; Muhammad Sajid Hussain
Journal:  Mol Genet Genomic Med       Date:  2020-07-17       Impact factor: 2.183

8.  Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.

Authors:  Henrik Stranneheim; Kristina Lagerstedt-Robinson; Anna Lindstrand; Anna Wedell; Måns Magnusson; Malin Kvarnung; Daniel Nilsson; Nicole Lesko; Martin Engvall; Britt-Marie Anderlid; Henrik Arnell; Carolina Backman Johansson; Michela Barbaro; Erik Björck; Helene Bruhn; Jesper Eisfeldt; Christoph Freyer; Giedre Grigelioniene; Peter Gustavsson; Anna Hammarsjö; Maritta Hellström-Pigg; Erik Iwarsson; Anders Jemt; Mikael Laaksonen; Sara Lind Enoksson; Helena Malmgren; Karin Naess; Magnus Nordenskjöld; Mikael Oscarson; Maria Pettersson; Chiara Rasi; Adam Rosenbaum; Ellika Sahlin; Eliane Sardh; Tommy Stödberg; Bianca Tesi; Emma Tham; Håkan Thonberg; Virpi Töhönen; Ulrika von Döbeln; Daphne Vassiliou; Sofie Vonlanthen; Ann-Charlotte Wikström; Josephine Wincent; Ola Winqvist; Anna Wredenberg; Sofia Ygberg; Rolf H Zetterström; Per Marits; Maria Johansson Soller; Ann Nordgren; Valtteri Wirta
Journal:  Genome Med       Date:  2021-03-17       Impact factor: 11.117

Review 9.  Post-transcriptional control of cellular differentiation by the RNA exosome complex.

Authors:  Isabela Fraga de Andrade; Charu Mehta; Emery H Bresnick
Journal:  Nucleic Acids Res       Date:  2020-12-02       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.